Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs

Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the appointments of Jeltje Schulten, M.D., MBA, as SVP of clinical and medical affairs

Read the article: https://www.bioqubeventures.com/bicara-therapeutics-expands-clinical-team-with-appointments-of-jeltje-schulten-m-d-mba-as-svp-of-clinical-and-medical-affairs-and-rita-dalal-mbbs-mph-as-vp-of-clinical-development/

Participants

  • Jeltje Schulten
    Role: Alumni
    Reference type: Featured

Media Outlets

  • Bioqube Ventures (Magazine)